These companies show that specialization can be an excellent competitive strategy.
News & Analysis: Intra-Cellular Therapies
The potential label expansion of lumateperone in bipolar depression could be a major breakthrough.
A nice bounce for the market was overdue.
Investors are reacting enthusiastically to the company's latest clinical results.
ITCI earnings call for the period ending June 30, 2020.
ITCI earnings call for the period ending March 31, 2020.
ITCI earnings call for the period ending December 31, 2019.
The pharmaceutical company announced the pricing of a public stock offering. It's wisely taking advantage of a soaring stock price to raise cash ahead of a crucial market launch.
The company's first FDA-approved product could be a big hit.
The stock market posted gains to start the holiday week.